Dan Todd

519 total citations
8 papers, 392 citations indexed

About

Dan Todd is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Dan Todd has authored 8 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Dan Todd's work include Receptor Mechanisms and Signaling (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Adenosine and Purinergic Signaling (2 papers). Dan Todd is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Adenosine and Purinergic Signaling (2 papers). Dan Todd collaborates with scholars based in United States and United Kingdom. Dan Todd's co-authors include Shawn P. Williams, Katrina L. Creech, David N. Deaton, Aaron B. Miller, Derek J. Parks, Justin A. Caravella, Harry B. Marr, G. Bruce Wisely, Kevin P. Madauss and Robert B. McFadyen and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Dan Todd

8 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Todd United States 8 225 134 80 69 63 8 392
Harry B. Marr United States 10 224 1.0× 201 1.5× 118 1.5× 84 1.2× 58 0.9× 13 554
Grace Yan United States 9 161 0.7× 98 0.7× 21 0.3× 55 0.8× 35 0.6× 10 316
István Káldor United States 11 112 0.5× 123 0.9× 111 1.4× 62 0.9× 37 0.6× 21 482
Chantal Masungi Belgium 8 160 0.7× 128 1.0× 169 2.1× 105 1.5× 41 0.7× 8 503
Helen Gu United States 12 117 0.5× 112 0.8× 75 0.9× 64 0.9× 32 0.5× 19 507
Walid Karam Lebanon 12 148 0.7× 175 1.3× 22 0.3× 94 1.4× 16 0.3× 17 427
Rachel E. Kosa United States 11 233 1.0× 78 0.6× 35 0.4× 57 0.8× 41 0.7× 16 396
B. Kevin Park United Kingdom 13 93 0.4× 151 1.1× 61 0.8× 68 1.0× 27 0.4× 15 485
Lilly Xu United States 7 148 0.7× 87 0.6× 77 1.0× 48 0.7× 38 0.6× 8 425
Joseph F. Leone United States 11 66 0.3× 149 1.1× 101 1.3× 48 0.7× 17 0.3× 16 324

Countries citing papers authored by Dan Todd

Since Specialization
Citations

This map shows the geographic impact of Dan Todd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Todd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Todd more than expected).

Fields of papers citing papers by Dan Todd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Todd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Todd. The network helps show where Dan Todd may publish in the future.

Co-authorship network of co-authors of Dan Todd

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Todd. A scholar is included among the top collaborators of Dan Todd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Todd. Dan Todd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Caravella, Justin A., Lihong Chen, Katrina L. Creech, et al.. (2011). Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbene. Bioorganic & Medicinal Chemistry Letters. 21(20). 6154–6160. 28 indexed citations
2.
Duan, Maosheng, Wieslaw M. Kazmierski, Mark Edelstein, et al.. (2011). Discovery of a novel series of cyclic urea as potent CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(21). 6381–6385. 9 indexed citations
3.
Bass, Jonathan Y., Justin A. Caravella, Lihong Chen, et al.. (2010). Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene. Bioorganic & Medicinal Chemistry Letters. 21(4). 1206–1213. 53 indexed citations
4.
Bass, Jonathan Y., Richard D. Caldwell, Justin A. Caravella, et al.. (2009). Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064. Bioorganic & Medicinal Chemistry Letters. 19(11). 2969–2973. 45 indexed citations
5.
Bass, Jonathan Y., Richard D. Caldwell, Justin A. Caravella, et al.. (2009). FXR agonist activity of conformationally constrained analogs of GW 4064. Bioorganic & Medicinal Chemistry Letters. 19(16). 4733–4739. 56 indexed citations
6.
Bass, Jonathan Y., Richard D. Caldwell, Justin A. Caravella, et al.. (2008). Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064. Bioorganic & Medicinal Chemistry Letters. 18(15). 4339–4343. 118 indexed citations
7.
Furfine, Eric S., Christopher Baker, Michael Hale, et al.. (2004). Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir. Antimicrobial Agents and Chemotherapy. 48(3). 791–798. 73 indexed citations
8.
Pacofsky, Gregory J., Jeffrey A. Stafford, Richard F. Cox, et al.. (2002). Relating the Structure, Activity, and Physical Properties of Ultrashort-Acting Benzodiazepine Receptor Agonists. Bioorganic & Medicinal Chemistry Letters. 12(21). 3219–3222. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026